{"chunk_id": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue__chunk_11", "source": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue", "text": "reference available interventions for monitoring or mi tigating the \nadverse reactions presented elsewhere in the labeling. In addition, the labeling must also include pertinent information abou t the \ndata that are the basis for the risk summary and clinical information included in this section. \n \n4. The Females and Males of Reproductive Potential subsection (8.3), new to the labeling, includes information, when necessary, \nabout the need for pregnancy testing, contraception recommendations, a"}